Lymphoblastoid cells exhibit elevated CD58 expression and diminished CD81 expression relative to normal hematopoietic cells, allowing the CD81/CD58 expression ratio to serve as a diagnostic tool for distinguishing between hematopoietic and lymphoblastoid cells in BCP-ALL cases (45). The gene discussed is CD58; the disease is acute lymphoblastic leukemia.